Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Sense Biodetection
company
About
Sense Biodetection Limited is a molecular diagnostics company .
- 51 - 100
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- £500K
- Industries
- Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2014
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Sense Biodetection Limited is a molecular diagnostics company focused on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
£11M $50M
Sense Biodetection has raised a total of
£11M $50M
in funding over 2 rounds. Their latest funding was raised on
Apr 20, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 20, 2021 | Series B | $50M | 1 | — | — | Detail |
| Oct 28, 2019 | Series A | £10.50M | 1 |
Cambridge Innovation Capital
|
— | Detail |
| Jul 20, 2016 | Seed | £500K | 1 |
Mercia Fund Managers
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Sense Biodetection is funded by 2 investors.
Mercia Fund Managers
and Cambridge Innovation Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mercia Fund Managers
|
Yes | Seed |
|
Cambridge Innovation Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
